Cargando…
An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
Autores principales: | Terrazzano, Giuseppe, Rubino, Valentina, Palatucci, Anna Teresa, Giovazzino, Angela, Carriero, Flavia, Ruggiero, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273850/ https://www.ncbi.nlm.nih.gov/pubmed/32574238 http://dx.doi.org/10.3389/fphar.2020.00856 |
Ejemplares similares
-
Bone marrow CD3
(+)
CD56
(+) regulatory T lymphocytes (T(R3)
(−56) cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients
por: Leone, Stefania, et al.
Publicado: (2022) -
Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
por: Rubino, Valentina, et al.
Publicado: (2021) -
Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease
por: Rubino, Valentina, et al.
Publicado: (2023) -
Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs
por: Piantedosi, Diego, et al.
Publicado: (2020) -
Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
por: Ercolano, Giuseppe, et al.
Publicado: (2019)